Erica Weinstein
Fundador en Profound Therapeutics .
Perfil
Erica Weinstein is the founder of Profound Therapeutics, a company founded in 2020.
She is currently working as a Senior Principal at Flagship Pioneering since 2015.
Dr. Weinstein has an undergraduate degree from Emory University and a doctorate degree from Icahn School of Medicine at Mount Sinai.
Cargos activos de Erica Weinstein
Empresas | Cargo | Inicio |
---|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Inversor de Capital Privado | 01/01/2015 |
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then. | Fundador | 01/01/2020 |
Formación de Erica Weinstein.
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Emory University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then. | Health Technology |
- Bolsa de valores
- Insiders
- Erica Weinstein